Credit Suisse Ag Boston Scientific Corp Call Options Transaction History

Credit Suisse Ag

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $127,812 - $142,228	-3,100 Reduced 3.97%	75,000 $3.25 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $1.47 Million - $1.69 Million	-38,100 Reduced 32.79%	78,100 $3.38 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $11.6 Million - $13.1 Million	-329,700 Reduced 73.94%	116,200 $4.49 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $13.7 Million - $17.3 Million	412,500 Added 1235.03%	445,900 $16 Million
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $997,037 - $1.76 Million	-38,600 Reduced 53.61%	33,400 $1.09 Million
Q3 2019 Nov 12, 2019	SELL	$40.31 - $43.45 $2.54 Million - $2.74 Million	-63,000 Reduced 46.67%	72,000 $2.93 Million
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $544,978 - $641,258	16,600 Added 14.02%	135,000 $5.2 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $3.11 Million - $3.45 Million	118,400	118,400 $3.45 Million

1,542

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $131B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.